Affiliation:
1. Universidade Estadual de Campinas, Brazil; Universidade Estadual de Campinas, Brazil
2. Universidade Estadual de Campinas, Brazil
3. Universidade de São Paulo, Brazil
4. Universidade Federal de São Paulo, Brazil
Abstract
Abstract Introduction: The epidemiologic profile of renal osteodystrophy (ROD) is changing over time and cross-sectional studies provide essential information to improve care and health policies. The Brazilian Registry of Bone Biopsy (REBRABO) is a prospective, nationalmulticenter cohort that includes patients with chronic kidney disease (CKD) undergoing bone biopsy. REBRABO aims to provide clinical information on ROD. The main objective of this subanalysis was to describe the profile of ROD, including clinically relevant associations. Methods: From Aug/2015 to Dec/2021, 511 patients with CKD who performed bone biopsy were included in the REBRABO platform. Patients with no bone biopsy report (N = 40), GFR > 90 mL/min (N = 28), without asigned consent (N = 24), bone fragments inadequate for diagnosis (N = 23), bone biopsy indicated by a specialty other than nephrology (N = 6), and < 18 years old (N = 4) were excluded. Clinical-demographic data (e.g., age, sex, ethnicity, CKD etiology, dialysis vintage, comorbidities, symptoms, and complications related to ROD), laboratory (e.g., serum levels of total calcium, phosphate, parathormone, alkaline phosphatase, 25-hydroxyvitamin D, and hemoglobin), and ROD (e.g., histological diagnosis) were analyzed. Results: Data from 386 individuals were considered in this subanalysis of REBRABO. Mean age was 52 (42–60) years; 198 (51%) were male; 315 (82%) were on hemodialysis. Osteitis fibrosa (OF) [163 (42%)], adynamic bone disease (ABD) [96 (25%)] and mixed uremic osteodystrophy (MUO) [83 (21%)] were the most frequent diagnosis of ROD in our sample; 203 (54%) had the diagnosis of osteoporosis, 82 (56%) vascular calcification; 138 (36%) bone aluminum accumulation, and 137 (36%) iron intoxication; patients with high turnover were prone to present a higher frequency of symptoms. Conclusions: A high proportion of patients were diagnosed with OF and ABD, as well as osteoporosis, vascular calcification and clinical symptoms.
Reference17 articles.
1. Clinical and economic burden of fractures in patients with renal osteodystrophy.;Schumock GT;Clin Nephrol.,2007
2. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease.;Moe SM.;Eur J Clin Invest.,2006
3. Effect of CKD-MBD phenotype on health-related quality of life in patients receiving maintenance hemodialysis: a cross-sectional study.;Luo L;J Int Med Res.,2020
4. Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion.;Kovesdy CP;Clin J Am Soc Nephrol.,2008
5. Prevention of aluminium exposure through dialysis fluids. Analysis of changes in the last 8 years.;Fernández-Martín JL;Nephrol Dial Transplant.,1998
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献